MERRILL GOOZNER Medicare has reinstated payment codes for eye specialists who use Genentech's Avastin to treat wet macular degeneration. A tiny amount of Avastin, which is sold for cancer treatments, successfully treats the condition at about $100
Read More...
Read the complete post at http://www.thehealthcareblog.com/the_health_care_blog/2009/10/cms-reinstates-paying-for-avastin-used-offlabel-for-macular-degeneration.html
Posted
Oct 29 2009, 09:00 PM
by
The Health Care Blog